Noxopharm Limited announced the appointment of Dr. Greg van Wyk as its Chief Medical Officer. Dr. van Wyk is an experienced pharmaceutical industry physician who has led medical teams across Australasia and North-Western Europe. Dr. van Wyk joins the company at a time of significant growth in the company's clinical and pre-clinical programs and will play a key bridging role with the company's medical advisors to plan and direct those programs.